TGFB1 and diabetes mellitus: The PI3K/AKT signaling pathway is important for insulin signaling and glucose metabolism, lymphocyte migration, proliferation, and differentiation, and TGF-β signaling regulation, making it an important therapeutic target for the treatment of cancer, diabetes, and other diseases [41].